We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
EHC Opens New Lake Worth Rehab Hospital to Meet Rising Demand
Read MoreHide Full Article
Key Takeaways
Encompass Health opened a 50-bed Lake Worth rehab hospital to support complex patient recovery needs.
EHC's facility includes private rooms, advanced therapy tech, in-house dialysis and continuous nursing care.
Encompass Health adds its 26th Florida location as rising rehab demand drives continued network growth.
Encompass Health Corporation (EHC - Free Report) recently opened its new Encompass Health Rehabilitation Hospital of Lake Worth, marking another milestone in the company’s rapid expansion across Florida. This facility features 50 beds and is designed to help patients on their journey to recover from complex medical issues like strokes, brain injuries, major orthopedic surgeries and amputations.
It features private patient rooms and a spacious therapy gym filled with cutting-edge rehabilitation technologies for every mobility level, an in-house dialysis unit, an activities-of-daily-living suite, convenient in-house pharmacy services and much more. The treatment plans involve a minimum of three hours of therapy five days a week, along with 24/7 nursing care and consistent oversight from physicians.
The interdisciplinary care model is a key part of Encompass Health’s approach, making sure that treatment plans are tailored to help patients regain their mobility, independence and overall quality of life in the long run. This expansion highlights the increasing need for rehab services as the U.S. population ages and chronic health conditions increase. Also, EHC is committed to providing top-notch care options close to patients’ homes.
By setting up a facility in the area, the company not only meets the needs of locals but also strengthens its network. This facility marks EHC’s 26th location in the state of Florida (including a satellite location in The Villages). At present, the company operates 173 rehabilitation hospitals across 39 states and Puerto Rico.
EHC’s footprint positions it well to capture sustained growth in the post-acute care segment. Its net operating revenues increased 10.6% year over year in the first nine months of 2025. The company plans to open seven de novo hospitals in 2025, along with a 50-bed satellite facility, and add around 127 beds to existing hospitals, further strengthening its national footprint.
EHC’s Price Performance
Year to date, EHC shares have gained 23.3% compared with the industry’s growth of 10.3%.
The Zacks Consensus Estimate for BrightSpring Health Services’ current-year earnings of $1.12 per share has witnessed one upward revision in the past 30 days against no movement in the opposite direction. BrightSpring Health Services beat earnings estimates in each of the trailing four quarters, with the average surprise being 45.1%. The consensus estimate for current-year revenues is pegged at $12.7 billion, suggesting 12.8% year-over-year growth.
The Zacks Consensus Estimate for Universal Health’s current-year earnings of $21.83 per share has witnessed four upward revisions in the past 30 days against no movement in the opposite direction. Universal Health beat earnings estimates in each of the trailing four quarters, with the average surprise being 15.2%. The consensus estimate for current-year revenues is pegged at $17.4 billion, suggesting 9.7% year-over-year growth.
The Zacks Consensus Estimate for Veracyte’s current-year earnings of $1.65 per share has witnessed four upward revisions in the past 30 days against no movement in the opposite direction. Veracyte beat earnings estimates in each of the trailing four quarters, with an average surprise being 45.1%. The consensus estimate for current-year revenues is pegged at $508.6 million, suggesting 14.1% year-over-year growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
EHC Opens New Lake Worth Rehab Hospital to Meet Rising Demand
Key Takeaways
Encompass Health Corporation (EHC - Free Report) recently opened its new Encompass Health Rehabilitation Hospital of Lake Worth, marking another milestone in the company’s rapid expansion across Florida. This facility features 50 beds and is designed to help patients on their journey to recover from complex medical issues like strokes, brain injuries, major orthopedic surgeries and amputations.
It features private patient rooms and a spacious therapy gym filled with cutting-edge rehabilitation technologies for every mobility level, an in-house dialysis unit, an activities-of-daily-living suite, convenient in-house pharmacy services and much more. The treatment plans involve a minimum of three hours of therapy five days a week, along with 24/7 nursing care and consistent oversight from physicians.
The interdisciplinary care model is a key part of Encompass Health’s approach, making sure that treatment plans are tailored to help patients regain their mobility, independence and overall quality of life in the long run. This expansion highlights the increasing need for rehab services as the U.S. population ages and chronic health conditions increase. Also, EHC is committed to providing top-notch care options close to patients’ homes.
By setting up a facility in the area, the company not only meets the needs of locals but also strengthens its network. This facility marks EHC’s 26th location in the state of Florida (including a satellite location in The Villages). At present, the company operates 173 rehabilitation hospitals across 39 states and Puerto Rico.
EHC’s footprint positions it well to capture sustained growth in the post-acute care segment. Its net operating revenues increased 10.6% year over year in the first nine months of 2025. The company plans to open seven de novo hospitals in 2025, along with a 50-bed satellite facility, and add around 127 beds to existing hospitals, further strengthening its national footprint.
EHC’s Price Performance
Year to date, EHC shares have gained 23.3% compared with the industry’s growth of 10.3%.
Image Source: Zacks Investment Research
EHC’s Zacks Rank & Key Picks
EHC currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Medical space are BrightSpring Health Services, Inc. (BTSG - Free Report) , Universal Health Services, Inc. (UHS - Free Report) and Veracyte, Inc. (VCYT - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for BrightSpring Health Services’ current-year earnings of $1.12 per share has witnessed one upward revision in the past 30 days against no movement in the opposite direction. BrightSpring Health Services beat earnings estimates in each of the trailing four quarters, with the average surprise being 45.1%. The consensus estimate for current-year revenues is pegged at $12.7 billion, suggesting 12.8% year-over-year growth.
The Zacks Consensus Estimate for Universal Health’s current-year earnings of $21.83 per share has witnessed four upward revisions in the past 30 days against no movement in the opposite direction. Universal Health beat earnings estimates in each of the trailing four quarters, with the average surprise being 15.2%. The consensus estimate for current-year revenues is pegged at $17.4 billion, suggesting 9.7% year-over-year growth.
The Zacks Consensus Estimate for Veracyte’s current-year earnings of $1.65 per share has witnessed four upward revisions in the past 30 days against no movement in the opposite direction. Veracyte beat earnings estimates in each of the trailing four quarters, with an average surprise being 45.1%. The consensus estimate for current-year revenues is pegged at $508.6 million, suggesting 14.1% year-over-year growth.